IO Biotech's cancer vaccines shows improvement in late-stage study goal-March 2024-www.financetom.com

IO Biotech's cancer vaccines shows improvement in late-stage study goal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

IO Biotech's cancer vaccines shows improvement in late-stage study goal

Aug 11, 2025 5:24 AM

Aug 11 (Reuters) - IO Biotech ( IOBT ) said on Monday

its experimental cancer vaccine in combination with Merck's ( MRK )

Keytruda showed improvement in a late-stage study goal,

but was not statistically significant.

(Reporting by Sneha S K in Bengaluru)

Previous page： Government must do away with excise duty on petrol, diesel, says Mriganka Jaipuriyar Next page： New Zealand, Kei Runga Noa Atu Koe!

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Government must do away with excise duty on petrol, diesel, says Mriganka Jaipuriyar

May 18, 2018

Indian government could do away with excise taxes on petrol and diesel, said Mriganka Jaipuriyar, News Editor, Oil & Gas...

New Zealand, Kei Runga Noa Atu Koe!

May 18, 2018

So you criss-cross the land in a rental car, and discover why Lord Of the Rings was shot here.

Expect 15% topline growth in FY19, says Skipper Ltd

May 18, 2018

We expect 15% topline growth in FY19, said Devesh Bansal, Director, Skipper Ltd, in an interview to CNBC-TV18. Skipper reported...

Expect to repay debt of Rs 26 crore, says IOL Chemicals

May 18, 2018

We expect to repay the debt of Rs 26 crore, said Vijay Garg, joint Managing Director, IOL Chemicals and Pharmaceuticals....